ALTME — TME Pharma NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for TME Pharma NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10.3	9.48	4.63	2.25	3.25
Net Total Receivables	0.069	0.081	0.279	0.041	0.026
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10.5	9.69	5.01	2.39	3.36
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.118	0.066	0.221	0.096	0.034
Net Intangible Assets
Long Term Investments
Total Assets	10.7	9.77	5.24	2.49	3.41
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.9	5.27	6.45	2.79	1.79
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	2.94	5.25	6.51	2.79	1.79
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	7.71	4.51	-1.27	-0.294	1.61
Total Liabilities & Shareholders' Equity	10.7	9.77	5.24	2.49	3.41
Total Common Shares Outstanding